Tulane University School of Medicine
New Orleans, LA
Dr. Fonseca receives honoraria for consulting and speaking for Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Novo Nordisk, Sanofi-Aventis and Takeda. He has received research grants from Abbott, Eli Lilly, Endo Barrier, Novo Nordisk, Pan American Laboratories, Reata and Sanofi-Aventis.
Vivian A. Fonseca, MD, FRCP, is Professor of Medicine, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of Endocrinology at Tulane University Medical Center in New Orleans, Louisiana. He is currently immediate Past-President for Science and Medicine of the American Diabetes Association.
He is Editor in Chief of the Journal of Diabetes and its Complications. He was Editor in chief of Diabetes Care from 2007-2011, having formerly been associate editor. He was until 2006 Editor in Chief of the Journal of the Metabolic Syndrome and related disorders. He served on the editorial board of the Journal of Clinical Endocrinology and Metabolism (2003-2006). He is an ad hoc reviewer for several other journals, including New England Journal of Medicine, JAMA, Diabetes, Diabetic Medicine, Kidney International, the American Journal of Clinical Nutrition, the British Medical Journal, and Metabolism.
Dr. Fonseca has served on and been chairman of the clinical practice committee of the American Diabetes Association, the ADA Disaster Task Force, ADA strategic planning committee and the joint ADA/ACC "Make the Link" Program.
Dr. Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London), and the American College of Physicians. He is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on several national and international committees, and has published over 200 papers, review articles and book chapters.
Dr. Fonseca's current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. He has a research program evaluating inflammation as risk factors for heart disease in diabetes and using technology to improve diabetes care in underprivileged populations. He is also an investigator in the NIH-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD/ ACCORDION) study and serves on the Glycemia control committee and the GRADE study. He is a co- Investigator on the NIH TINSAL -2D study and serves on the Steering and Ancillary studies committees. Dr. Fonseca has lectured in the United States and abroad. He has published over 300 papers and is the editor of the text book "Clinical Diabetes: Translating Research into Practice" (El Sevier) and several monographs and book chapters.
You need to be logged in to save this episode to a playlist.